Intuitive IP, Inc. today announced that the company had entered into an exclusive patent licensing agreement with Stryker Corporation, a Fortune 500 medical technology company.  The licensing agreement, which covers patents directed at Stryker’s Vital-Flo technology, is the latest partnership between these two companies seeking to utilize neuro-muscular electrical stimulation to help prevent the occurrence of deep vein thrombosis.

Deep vein thrombosis (DVT) is the formation of a blood clot (thrombosis) within a deep vein, most commonly the legs.  Pulmonary embolism (PE), a potentially life-threatening complication, is caused by the detachment of a clot that travels to the lungs.  Together, DVT/PE account for over 100,000 deaths in the United States each year.